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Genome Wide Association Studies (GWAS) have increasingly furthered our 
understanding of the molecular basis of many complex traits by finding, through 
genotyping and imputation, loci associated with many different traits. However, 
studies based on variants present in common genotyping arrays and imputation 
panels may not capture the fraction of human genome variation that is rare or 
geographically restricted and unique to specific populations. 
Here we propose the analysis of the genome of 2120 Sardinian individuals 
generated with next generation sequence approach and we will show the 
benefits, in terms of resolution and investigation, to the analysis of the Sardinian 
specific variability. 
1.1. From Genome Wide Association Studies to 
Next Generation Sequencing, motivations 
Genome Wide Association Studies (GWAS) are methods to investigate 
associations with complex traits or diseases by scanning Single Nucleotide 
Polymorphisms (SNPs). SNPs are genotyped using dense arrays having hundreds 
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main assumptions: the first one is that common variants with low effects are 
responsible of common diseases. Therefore, to detect such variants, we need a 
large number of individuals (typically greater than 6000) to achieve enough 
statistical power. The second assumption is that, by genotyping a reduced amount 
of SNPs (tag SNPs) along the genome, it is possible to access other markers by 
linkage disequilibrium (LD). Human genome, in fact, constitutes of haplotypes 
blocks and by typing a single SNP we can reconstruct the genotypes of other 
SNPs in the same block of LD by using statistical methods like imputation. 
Since 2005, GWAS studies reported more than 1000 SNPs associated with 
more than 300 complex traits or diseases[1], testifying the validity and the 
worldwide popularity of this approach. However, the approach has two 
important limitations that may reduce the statistical power in detecting 
associations. The first limitation comes from the genotyping arrays, the SNPs 
present in the arrays are selected from populations included in large international 
projects like HapMap[2]. When investigating isolated population, like Sardinians, 
it is possible that the assumption of LD disequilibrium between tags and the 
remaining SNPs is violated in some regions. In this case, the accuracy of 
imputation will be affected as well as the statistical power of detecting the 
associations. The second limitation of GWAS comes from the analysis of rare 
variants. Rare variants have lower LD with the surrounding SNPs and it is much 
harder to access them by using tag SNPs. Furthermore rare variants are, in 
general, population specific and it is much more likely that they are completely 
missed from GWAS analysis, since they are not included in commercial arrays or 
reference panel. 
In opposition to GWAS, Next Generation Sequencing (NGS) approaches 
aim to overcome these limitations by sequencing the complete genome. The 
approach is based on sequencing short read fragments, aligning them to the 
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positions that differ from the reference. The variants discovery is not dependent 
on the technology and potentially it is possible to genotype all the variants in the 
dataset without recurring to tag SNPs or imputation. We will use this approach to 
sequence a total of 2120 Sardinian individuals and generate a better map of the 
variability present in the Sardinians. The sequenced samples are selected from 
two larger cohorts of Sardinian individuals. 
  
1.2. The SardiNIA project 
The SardiNIA[3] project aims to investigating the aging in the Sardinians by 
analyzing more than 300 quantitative traits to evaluate how they correlate with 
age. The phenotypes encompass a large set of traits, hematological (blood cells 
count, lipid levels etc), anthropometric (waist circumference, height etc) but also 
personality and are collected every 3 years to understand their variation during 
lifetime. More recently, the study focused its attention to the count of different 
cell types by means of fluorescence-activated cell sorting (FACS).    
 The study started in 2001 and currently involves almost 7000 individuals 
from the Lanusei valley in the most isolated part of eastern Sardinia. The samples 
have been collected in families, so far almost 1000 pedigrees are available, they 
are up to 5 generations deep and the largest family has more than 625 genotyped 
individuals. The idea is to exploit the familial relationships to ease the analysis of 
rare variants shared between individuals of the same family having similar 
phenotype.   
So far, the study genotyped the individuals using whole genome GWAS 
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arrays (Metabochip, Exomechip, Immunochip). Imputation was performed using 
the previously available reference panel like HapMap or 1000 Genomes.  
The study has given a large contribution to the GWAS literature by 
publishing more than 60 papers since 2006, confirming the quality and validity of 
the analysis and data produced. After the start of the sequencing project, the 
project is focusing on the analysis of rare and Sardinian specific variants 
responsible for variations in the available phenotypes. 
 
1.3. Autoimmunity in Sardinia 
The autoimmunity project is a large genotyping project on Sardinia 
individuals motivated by the high incidence of autoimmune diseases in Sardinia. 
The study focuses its attention to Type-1 Diabetes (T1D) and Multiple Sclerosis 
(MS).  
Different studies of Multiple Sclerosis showed that, in general, northern 
European populations have higher incidence of MS. However the Sardinia is a 
complete outlier in the European distribution, being one of the regions with the 
highest incidence and with an extremely large difference when compared to 
other regions in the Mediterranean area[4] (see Figure 1 in the next page). Similar 
results can be found when analyzing the incidence of T1D.  
The study involves 8000 individuals from Cagliari and Sassari, enrolled in 
a case control study with ~2000 T1D cases, ~3000 MS cases and ~3000 controls. A 
strong requirement is that individuals must have 3 of the 4 grandparents born in 
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Figure 1: Prevalence (per 100,000 individuals) of MS in Europe[4] 
 
Samples, so far, have been genotyped using GWAS array Affymetrix 6.0 or 
Immunochip and have been imputed using HapMap and 1000 Genomes reference 
panel. Results detected the HLA signals, as expected, detected association signals 
with higher effect size in Sardinians compared to other populations (i.e. CBLB[5]) 
and were able to replicate some of the other loci found by other group studying 
the same disease. The study will benefit of the sequencing project in the 
investigation of rare variants and in the better genotyping of variants having 
different LD and frequencies between Sardinians and the 1000G populations. 
Furthermore, sequencing the HLA region, will give better insights of the HLA 






Detecting the Sardinian specific variability trough next generation sequencing of 2120 individuals 
Carlo Sidore - Tesi di Dottorato in Scienze Biomediche – Università degli Studi di Sassari 10 
 
 
2. Next Generation Sequencing: 
data generation  
In this chapter we will describe the data generation and the sequencing of 
our samples, highlighting the complex procedures needed to generate the 
complete dataset of sequenced individuals. Sequencing of our samples has been 
performed in parallel at the sequencing core of the University of Michigan and at 
the sequencing center of the CRS4 in Pula, Sardinia, using, in both cases, the 
Illumina technology. 
2.1. How sequencers work: Illumina technology 
We sequenced our samples using Illumina GAII and HIseq sequencers, 
based on a technology that reads pair-end of short DNA fragments. 
 DNA strands are sheared by means of sonication and adapters are ligated 
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Figure 2: Schematic of Illumina sequencing technology. 
Single stranded DNA fragments adapters bind to the flowcell (Figure 2b) 
and they are bridge-amplified creating, for each fragment, a copy of the same 
fragment on the opposite strand (Figure 2c). 
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At this point each of the two copies of the fragment is read independently 
base by base (Figure 3). At the end of the process we will have two non 
overlapping reads for each fragment which will map in the same genomic region 
after being complemented to be in the same strand.  
 
2.2. Alignment, recalibration, quality checks 
Data produced by the Illumina raw data processing need to be further 
analyzed to be used for genetic analyses. Here we will describe the procedure to 
generate individual level Binary Alignment/Map(BAM) file  starting from 
Illumina raw data. 
2.2.1. Mapping to the human reference genome 
 Raw data are generated by reading small fragments of DNA without 
knowing their position in the genome. The first step of analysis is the mapping to 
the reference genome that we performed using the software BWA[7]. We used, as 
genomic reference, the same file used by 1000 Genomes project, it is based on 
genomic build 37 and contains decoy sequences to remove problems due to hard-
to-map regions. The mapping procedure consists in indexing the reads and 
mapping them to the reference. The mapping exploits the pair-end sequencing to 
increase the mapping accuracy, by verifying that both ends of the fragment map 
in the same genomic region. Aligned data are stored in BAM files, the standard 
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2.2.2. Duplicate removal 
The next step of the sample preparation is the PCR duplicate removal. 
Illumina sample preparation involves DNA amplification by PCR, which  
generates errors in DNA fragments that may be amplified resulting in multiple 
copies carrying the same error. Even if it is not possible to recognize the PCR 
errors, it is possible however to identify multiple PCR copies of the same 
fragment. In fact, copies of the same fragment will be mapped to the same 
position in the genome reference. If two or more copies with the same genomic 
position are detected, only the copy with the highest mean quality is kept and the 
remaining copies are discarded from further analyses. 
2.2.3. Recalibration 
Last step of sample preparation is the quality score recalibration. Prior to 
this step, Illumina pipeline assigns a quality score to each base proportional to the 
quality of sequencer reading. For variants detection, however, it is important to 
know a better estimation of the true per-base-error rate which may be obtained 
by recalibration. Recalibration combines together bases having the same features 
(same sequencing cycle, same dinucleotide bases, same Illumina quality score) 
and compare them to the reference genome. To avoid bias to the error rate due to 
real mutations, positions known as SNPs are discarded. For each group of 
variants, the recalibration algorithm evaluates the mismatch rate with the 
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2.2.4. Quality and identity checks   
Finally, we performed quality controls on the processed bam files, 
evaluating the recalibrated quality, the number of reads and the mean depth. In 
case of mean base quality <20 or depth lower than 2x, the samples were discarded 
from the further analysis and eventually resequenced. We also used 
verifyBamID[8] to verify the correct identity of each sample, avoiding sample 
swaps. The software evaluates the IBD between the sequenced sample, before 
variant calling, and the same sample genotyped with GWAS arrays. 
 
3. Variant calling 
The variant calling identifies the variants present in our dataset after 
comparing the sequences to the reference. The whole process requires many 
complex steps: the generation of base likelihoods at each position, the 
identification of variant sites, the filtration of technical artifacts and finally the 
refinement of genotypes by using linkage disequilibrium information of neighbor 
SNPs. To execute such a complex pipeline, we used and collaborated in the 
development of the UMAKE[9] pipeline. The pipeline allows to automating all the 
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Figure 4: Workflow of the UMAKE pipeline  
3.1. Likelihoods generation 
This preliminary step generates 10 likelihoods (1 for each possible 
genotype AA, AC, AG, AT, CA….TC, TG, TT) at each position of the genome by 
extracting the base qualities of each nucleotide from the reads covering the 
position. Before generating the likelihoods, two corrections are applied to the 
aligned reads: Base Adjustment Quality (BAQ) and clipOverlap. The BAQ reduces 
artifacts due to indels by downgrading qualities at the end of the reads[10]. The 
clipOverlap reduces the bias generated by PCR errors generated by short reads 
with overlapping ends[11]. In this step each individual is analyzed separately and 
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3.2. Variant caller 
The variant caller scans the genome to identify a preliminary list of sites 
with at least one genotype different from the reference. In this step, we used a 
population-based approach that, for each position, analyzes all the individuals 
together. Since majority of the variants are shared among samples, the approach 
increases the power to detect variants, especially at positions with low coverage, 
and reduces false positives. The algorithm, after evaluating the likelihoods of all 
the individuals at each position, generates the probability of the sites being a 
variant. This probability is weighted with prior probabilities, derived from 
expected mutation rate in population genetics, to evaluate the final posterior 
probability of the site being a variant. If the posterior probability exceeds a 
specified threshold, the position is tagged as variant and genotypes are assigned to 
individuals who have coverage at the position. Genotypes, at this point, have low 
accuracy due to low coverage of the sequencing which, occasionally, may 
sequence only one of the two chromosomes and generate wrong genotypes. 
3.3. Variant filtration 
The list of variant sites generated after the variant calling contains a 
number of technical artifacts not detectable by an analysis based only on 
genotype likelihoods. For this reason, we perform further analysis on nucleotide 
distributions, base and read qualities to generate a better set of variant sites. As a 
measure of the quality of the variant sites, we evaluate the Ts/Tv ratio between 
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transversion (Tv) mutations (the 12 remaining ones). In the DNA the expected 
value of the ratio is higher than 2, since transitions are more common than 
transversion. Instead, in case of random mutations, generated for instance by 
technical artifacts, the value is 0.5, thus the Ts/Tv value can be used as a good 
indicator of filtering quality. In the following table, it is shown the Ts/Tv for 
different criteria of filtering, which have, as expected, Ts/Tv lower than 2 and 
close to 0.5.  
Filter # SNPs %dbSNP Ts/tv 
    AB70 9302 9.7 0.93 
AOI5 374 15.8 0.91 
INDEL5 5010 33.6 1.16 
STR20 8698 7.9 0.61 
STZ5 16460 16.5 0.86 
dp1160 4165 24 1.71 
str-20 8846 8.4 0.63 
stz-5 16975 16.5 0.89 
    Before filtering 422326 38.1 2.16 
Filtered 41545 18.8 0.97 
After filtering 380781 40.2 2.38 
Table 1: Ts/Tv for different filters on chromosome 20 and variants selected 
before and after filtering 
3.4.  Genotype refinement 
Genotypes generated by the variant caller, as mentioned previously, have 
high error rate due to low coverage sequencing of our samples. However 
genotype accuracy can be improved by taking into account linkage disequilibrium 
(LD) between SNPs. In fact, even unrelated individuals share short stretches of 
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genotypes in positions poorly covered.  
The algorithm uses a Hidden Markov Model approach, reconstructing 
haplotypes and LD blocks. In each iteration, the algorithm reconstructs each 
individual haplotypes configuration on the base of haplotypes found in the 
remaining individuals. Genotypes are continuously updated and used as reference 
until the algorithm completes the selected number of iterations. The result is a 
complete genotyping of the individuals at the positions detected by the variant 
caller and, more importantly, a complete reconstruction of the phased haplotypes. 
The phased haplotypes in fact, can be used as reference panel for imputation, as 




4. Sardinia Sequencing 
4.1. Study design: motivations 
The goal of our project is the investigation of Sardinian specific variation 
and, more in general, of the Sardinian variation not accessible by direct GWAS 
genotyping or after imputation on 1000G or HapMap.  
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dataset is the deep sequencing of all the individuals available to us. However the 
project would be extremely costly. Therefore we decided to choose a cheaper 
approach, by low pass sequencing a subset of 2120 individuals and to genotype in 
silico the remaining part of the cohort. In this chapter we will discuss the 
motivations behind our choices. 
4.1.1. Why a sequencing project? 
First of all, we decided to choose a sequencing project in opposition to a 
more extensive classical GWAS genotyping plus imputation, previously used in 
the past in our studies. The GWAS approach worked extremely well to detect 
common variation but also a fraction of rare variation shared between Sardinian 
and the public reference panel populations (typically Europeans). However, 
despite the large number of loci found associated with many different 
phenotypes, the variation detected by such approaches cannot explain the 
complete heritability of phenotypes. Some recent findings in our SardiNIA 
cohort, based on fine-mapping based arrays, like Metabochip, showed that a 
fraction of the missing heritability is due to rare variants not directly genotyped 
or tagged by proxies using previous GWAS platforms[12]. Furthermore some of the 
variability can be due to complex variants, like indels, CNV which would require 
additional genotyping to be analyzed. With a sequencing approach, we will be 
able to investigate the complete spectrum of variation, especially the Sardinian 
specific variation, and the complex variants, without additional genotyping. 
Furthermore, since we will generate a reference panel, we will be able to impute 
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4.1.2. Why a sequencing project in Sardinia? 
As mentioned previously, GWAS approaches have limitations in detecting 
the population specific variability. The variation not accessible by such 
approaches is proportional to the genetic distance between the population under 
analysis (i.e. Sardinians) and the population used as reference (i.e. Europeans). 
The Sardinian population has a large genetic distance (Fst) to other geographically 
neighbor populations. Published results[13] from the Human Genome Diversity 
Panel(HGDP) reports an Fst=5.3x10-3 with Italians and Fst=5.7x10-3 with North 
Italians, showing a pattern similar to other isolated populations, like Basque. 
Furthermore using PCA analysis Sardinian individuals have been found to be 
outliers in a genetic map of Europe[14]. 
 
Figure 5: The PCA genetic map matches the geographic map of Europe. Afterwards Italian 
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 For these reasons we expect that, compared to other non isolated 
populations, we will have a larger fraction of variation not accessible using 
GWAS arrays or reference panel based on European populations.  
4.1.3.Why whole genome low pass sequencing? 
Next generation sequencing approaches offer many different study designs 
and possible alternatives on the number of individuals to sequence, on the 
genomic regions and on the coverage( the number of reads for each position). In 
this paragraph we will discuss the possible alternatives and the reasons behind 
our choices. 
The best method to investigate the complete variability of our sample 
would be whole genome deep sequencing (30x or more) of all individuals present 
in our dataset. This approach would give us the possibility to investigate the 
whole genome with very good genotyping accuracy and a good assessment of rare 
variants. However its costs are extremely large and, nowadays unfeasible, thus we 
will need to reduce the amount of sequences generated by reducing the number 
of individuals sequenced or by reducing the sequencing coverage.  
Published results[15], based on simulations on 45000 chromosomes, show a 
comparison between two different approaches using the same amount of 
sequencing (12000x), sequencing of 3000 individuals at 4x or sequencing of 400 
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Population Maf (%) 0.1–0.2 0.2–0.5 0.5–1 1–2 2–5 >5 
Statistic Design 
      
% Discovery 
400@30x 65.4% 87.1% 100.0% 100.0% 100.0% 100.0% 




400@30x 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
3000@4x 99.8% 99.7% 99.6% 99.7% 99.6% 99.8% 
Heterozygote 
concordance 
400@30x 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
3000@4x 82.4% 81.9% 90.3% 97.2% 98.8% 99.8% 
Dosage r2 
400@30x 99.4% 99.6% 99.7% 99.8% 99.8% 99.9% 
3000@4x 63.9% 68.9% 80.2% 91.9% 95.7% 99.2% 
Information 
content  
(n * r2) 
400@30x 398 398 399 399 400 400 
3000@4x 1917 2069 2406 2758 2873 2978 
Table 2: Comparison of high-coverage (400 @ 30X) and low-coverage (3000 @ 4x) sequencing 
designs, given the same total sequencing effort. Simulated data. 
 
Looking at discovery of variants present in the population, we can see that 
for variants with frequency higher than 0.5 % both approaches behave in the 
same way discovering 100% of variability. At lower frequencies, as expected, both 
approaches miss a fraction of the variation in the 45000 chromosomes, due to the 
low number of individuals sequenced in the case of 400 individuals at 30x 
coverage and to the low coverage in case of the design with 3000 individuals at 
4x. 
The design with 400 individuals at 30x coverage shows much better 
concordance with genotypes and better accuracy after imputation (dosage r2). 
Instead, looking at the effective sample size (information content), the design 
with 3000 individuals, even with the 66% reduction at lowest frequencies, 
outperforms the design with 400 individuals, whose sample size cannot exceed 
the fixed limit of 400. 
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population, a better parameter of interest is the statistical power to detect 
population signals using different depth of sequencing plus imputation in the 
remaining individuals not sequenced in the cohort. 
 
 
Population Minor Allele Frequency 
Design 0.1% 0.5% 1% 3% 
400@30x 4.00% 6.40% 7.40% 11.60% 
400@30x + imputation in remaining 2600 10.40% 14.20% 15.00% 34.60% 
1000@12x 12.20% 13.40% 14.60% 17.80% 
1000@12x + imputation in remaining 2000 15.60% 20.80% 25.60% 41.80% 
2000@6x 54.40% 57.80% 61.60% 82.20% 
2000@6x + imputation in remaining 1000 56.20% 59.40% 61.80% 83.60% 
3000@4x 61.60% 75.60% 82.80% 90.40% 
Table 3 : Comparison of power to detect disease-SNP association 
 
The power of detecting signals is much higher in the design with 3000 
individuals sequenced at 4x because of the large number of individuals sequenced, 
which contain a larger number of variants (especially rare). This allows to 
including them in the reference panel and more importantly to have multiple 
copies of rare haplotypes which may be imputed with better accuracy. 
 
4.2. Imputation using reference panels from 
sequencing 
GWAS studies require large sample size to detect low effect association 
signals, however sequencing costs are currently too large to make possible to 
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decided to sequence only a subset of the samples in our cohorts and to genotype 
in silico, trough imputation, the remaining part of the cohort, using the reference 
panel generated from sequence. 
 
4.2.1. A population based reference panel 
The variant calling pipeline described in chapter 3 generates a dataset 
containing a phased haplotypes for each sequenced individual at the positions 
filtered after variant calling. We used these phased haplotypes to build a 




Figure 6: Workflow of imputation of sequence into GWAS genotypes 
 
Starting with the 2120 individuals sequenced at 4x coverage, we removed 
the related samples (mostly child of a trios) and we generated a reference panel 
containing 2976 (1488 individuals x 2 ) phased haplotypes. 
In parallel with the sequencing project we genotyped, using GWAS 
commercial arrays, a total of 15,000 samples, from the 2 projects described in 
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We then combined the two datasets using imputation, genotyping in silico  
the 15,000 samples from the two projects at the 17 million variants generated by 
sequencing. 
 
4.2.2. Comparison with 1000G reference panel 
To better understand the benefits of a population based reference panel, 
we performed a comparison between our panel and the most complete and large 
reference panel publicly available: the 1000G reference panel. The panel contains 
1092 individuals (sequenced at 4x), from 4 different macro areas in the world: 
Europe, Africa, Asia and America. Of these, 381 individuals belong to the 
European population, see chapter 5.3.1 for more details on other populations.  
 
 
Figure 7: Schematic of reference panels comparison, genotypes indicated by the blue arrows are 
used to evaluate imputation accuracy 
 
We compared the performances of the two reference panels by using two 
GWAS arrays in the Sardinia cohort. The genotypes from the first array (scaffold 
array) have been phased and used for imputation; the genotypes from the second 
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imputation. We removed the SNPs directly genotyped in the scaffold array to test 
only the SNPs genotyped in silico (indicated by blue arrows in the figure 7) and 
have a better estimation of the true imputation accuracy. We also excluded from 
the comparison the Sardinian individuals in common between the reference 




(sample size)  
Imputation accuracy (r2)  




56.2% 78.0% 86.7% 92.0% 
Sardinians 
(347) 
70.5% 87.6% 92.1% 95.6% 
1000G ALL 
(1092) 
59.2% 79.6% 87.1% 92.2% 
Sardinians 
(831) 
79.0% 92.0% 95.5% 97.1% 
Sardinians 
(1488) 
87.3% 94.8% 97.1% 98.2% 
Table 4: Comparison of the Sardinian and 1000G reference panels 
 
Comparing the first two reference panels with the same number of 
individuals (347 Sardinians versus 381 Europeans), it is possible to see that for 
common variation (MAF > 5%) both panels have good performances, with a 
correlation higher than 90%. When moving to lower frequencies, however, the 
Sardinian reference panel outperforms the 1000G reference panel, because the 
Sardinian reference panel contains the rare and population specific variation (and 
haplotypes) not present in the 1000G European individuals. Even including the 
whole set of 1092 individuals from 1000G it is possible to see the same trend. 
Notably, the inclusion of the individuals from Africa, Asia and America does not 
improve the imputation of common variation, meaning that 381 Europeans are 
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The small improvement in the lower frequencies is probably due to rare 
haplotypes shared between Africans and Sardinian not present in the Europeans. 
By increasing the sample size of the Sardinian reference panels, we can see 
a large increase in the different interval of frequency. Strikingly, the imputation 
accuracy of rare variants reaches 87.3% when using the latest panel with 1488 
panel.  
 
5. Sequencing results  
In this chapter we will describe the results of sequencing the 2120 
individuals, the number of variants detected, their accuracy and their quality. We 
will show some comparisons with the 1000G project variants, to understand how 
much of the Sardinia variability can be identified by other sequencing projects 
containing European individuals. Finally, we will show an example of application 
to the SardiNIA project to better understand how the next generation sequencing 
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5.1. Data freezes, effects of increasing number of 
individuals sequenced 
In opposition to GWAS studies, generation of sequence data takes a very 
long time, typically one week per 10 samples. In our case, it took 2 years to 
complete sequencing of the 2120 samples. For this reason, we decided to 
periodically generate data freezes with the available samples to evaluate the 




5.1.1. Variants discovered increasing number of 
individuals 
The project started in March 2010 and the first dataset, in June 2010, 
includes 66 individuals. Since then, we performed a total of 6 data freezes with 
increasing sample sizes that allowed us to continuously improving our methods of 
analysis and to testing how increasing sample size affects our population based 
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Figure 8: Data freeze timeline, with date and number of individuals for each data freeze 
 
An increasing in the number of individuals corresponds, as expected, to a large 
number of variants detected and more importantly to a large number of novel 
variants, not present in common database and then not accessible using GWAS 
approaches. These are the variants we are most interested in, since some of them 
may represent Sardinian specific variability that we would probably never access 
without using a sequencing approach on Sardinian individuals.  
 As mentioned before, we are using the Ts/Tv ratio as a measure of quality 
of our dataset. Its value is quite stable, confirming the quality of the variant sites 
in every data freeze. It is possible to see a small improvement in the latest data 
freezes, due to the improvements in analysis methods that we developed during 
the two years of our work that leaded to more sophisticated and accurate variant 
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5.1.2.Accuracy increasing number of individuals 
Since we are using a population approach, we expect that having more 
individuals will result in better variant calling and genotyping. To understand the 
size of this effect, we evaluated, for each data freeze, the heterozygous genotype 
concordance between the genotype generated by the sequencing approach after 
the genotype refinement and the Metabochip (a fine mapping based arrays that 
contains variants in the whole frequency spectrum). 
 
 
Figure 9: Mismatch rate between Metabochip GWAS genotypes and sequence genotypes after 
genotype refinement as a function of the number of individuals 
 
Results show a clear improvement in the genotype accuracy of sequence 
data, due to the increase of the number of individuals sequenced. By calling 
together more individuals  we have two major benefits. The first one is that it is 
easier to call a variant if it is carried by more than one individual. When calling a 
variant with frequency 1%, it appears as a singleton in 100 individuals, instead it 
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advantage to rare variants, which shows a better improvement in the accuracy. 
The second benefit affects the genotype refinement algorithm, by increasing the 
number of individuals we have a larger pool of haplotypes to assign to each 
individual, allowing a better reconstruction of the haplotipic configuration and 
then a better genotype and phasing accuracy.  
 
5.1.3. Saturation 
In the paragraph 5.1.1 we described how, by increasing the number of 
individuals, we obtain a larger number of variants. In this paragraph we will 
discuss the limits of number of variants found in the population and whether we 
can have an indication on the number of variants we may find by sequencing 
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Figure 10: Number of common variants (MAF > 10%) detected as a function of the number of 
individuals 
 
In the figure above, we are plotting the number of common variants 
(MAF> 10%) detected  as a function of the number of individuals. In this case, by 
sequencing one individual we find almost 60,000 variants (~60% of the total). By 
adding more individuals, up to 15, it is still possible to see an increment on the 
number of variants. After 20 individuals, however, the number of variants 
detected stops increasing since these 20 individuals already contains all the 
common variants in our dataset. 
Looking at different frequency bins, the pattern is similar but there are 
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Figure 11: Number of variants detected as a function of the number of individuals and of the 
minor allele frequency 
 
For MAF 1-10% (blue line) we find the same trend of the common 
variants, the number variants increase up to ~250 individuals then we reach the 
saturation since we detect all the variants in the dataset 
Before analyzing the frequency bin with MAF 0.1-1%, it is important to 
highlight individual’s distribution in the plot. The first 997 individuals are from 
the autoimmunity case control cohort from Cagliari and Sassari; the remaining 
1123 individuals are from the SardiNIA cohort in Lanusei, in the most isolated 
part of Sardinia. Looking at the black line (MAF 0.1-1%) there is a step at 1000 
individuals due to the introduction of the individuals from the SardiNIA cohort 
which belong to a different sub population with a different set of rare variants. 
Since the small step appears only in frequencies lower than 1%, we can conclude 
that there are not substantial difference in the variants with MAF >1% found in 
the two cohorts (even though there are some differences in the allelic frequencies 
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infer anything about the total number of variants present in Sardinia, since 
adding other Sardinian cohorts to our dataset may increase the number of 
variants in the frequency bin 0.1%-1%. 
Finally, by analyzing the frequency bin with MAF < 0.1%, we cannot find 
saturation on the number of variants, as expected, since this frequency bin 
include also the singletons and potentially every new individual added to the 
dataset carries a moderate amount of singletons. 
To conclude, even if we reach saturation of the number of variants for 
some frequencies bins, sequencing more individuals helps in the detection of rare 
variants and more importantly helps in genotyping with better accuracy the rare 
variation currently detected, which results in higher power to detect association’s 
signals generated by rare variants. 
5.2. Statistics on variants 
In this chapter we will focus our attention on the results of sequencing 
2120 individuals and on the number of variants detected. 
Before filtering, we detect a total of 19.4M variants with a Ts/Tv of 2.02, 
after applying the filters the number of variants reduced to 17.6 with a higher 












PASS 17,617,122 12,220,588 30.6 2.22 2.12 2.19 
FAIL 1,790,250 598,918 66.5 1.49 0.8 0.98 
TOTAL 19,407,372 12,819,506 33.9 2.18 1.76 2.02 
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To better evaluate the quality of our data we are evaluating the Ts/Tv ratio 
separately for known and novel variants. Known variants are detected by direct 
genotyping and confirmed also by other groups, so we expect that they have 
lower rate of false positives. Since, at genomic level, there should not be any 
difference between known and novel variant, we expect that the two categories 
have the same Ts/Tv ratio. Looking at the variants before filtering, we notice that 
there is a small imbalance (2.18 vs. 1.76), however, after filtering the imbalance 
disappears and the Ts/Tv ratio become more similar (2.22 vs. 2.12). 
The percentage of novel SNPs is 30.6%, however it is important to stratify 
the result by different minor allele frequencies. 
 
Figure 12: Distribution of known and novel SNPs among different minor allele frequencies 
 
Looking at the Figure 12, the common variants show a very small fraction 
of novel variants (0.4%). This is quite expected since they are shared worldwide, 
can be detected by other studies and then are already included in dbSNP 135.  
We detect a very large number of rare variants, ~30% of the variants has 
frequency lower than 1/1000 and ~50% of the variants has frequency lower than 
5/1000, under the expectation of population genetics theory. These two frequency 
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total of almost 5 millions of novel variants. Since they are so rare in Sardinia, they 
can be even rarer outside Sardinia, and therefore they probably will never be 
present in the individuals involved in public datasets. By using our sequencing 
approach we are able to genotype them trough sequencing and, more 
importantly, we are able to genotype them in silico in any Sardinian individuals 
genotyped with a GWAS array. 
Other than evaluating the raw number of individuals we evaluated the 
number of variants according to their functional annotation. 
  Genome  Synonymous  Nonsynonymous  Nonsense  
Total SNPs 17.6M 57,716 74,037 1,387 
Novelty rate 
dbSNP135 
30.6% 23.0% 35.0% 55.7% 
Table 6: #Variants according functional annotation 
 
As already mentioned, we found a total of 17.6 millions variants and 
31.6% of these are already in dbSNP 135.  
We also found 57,716 synonymous variants (23% novel) 74,037 non 
synonymous variants (35% novel) and interestingly 1387 nonsense variants (56% 
novel).  The higher rate of novel non-synonymous and nonsense variants can be 
explained by their frequency. In fact since they are altering or damaging, they 
have a lower frequency compared to synonymous and intronic variants whose 
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Per individual statistics 
  Genome Synonymous Nonsynonymous Nonsense 
5th percentile 3,376,149 10,359 9,006 57 
Mean 3,403,628 10,512 9,168 66 
95th percentile 3,427,757 10,664 9,322 76 
Table 7: Number of variants per individual 
 
Looking at the results at individual level, we find a mean of 3.4 millions 
variants per individual, with very small deviation in the whole dataset. In average 
we also find 10,512 synonymous and 9,168 non synonymous variants, in addition 
to 66 nonsense variants. At a first glance, the number of nonsense variants per 
individuals looks too high, but many of the non sense variants may belong to 
genes with no essential functionality.  Further studies are needed to evaluate the 
impact of these stop-codon variants. 
 
5.3. Sardinia vs. 1000 Genomes 
In this chapter we will compare the dataset we generated with the largest 
publicly available dataset generated with next generation sequencing. 
5.3.1. The 1000 Genomes project 
The 1000G project is an international cooperation, involving the most 
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worldwide common and rare variation by sequencing more than 1000 individuals 
from different parts of the world. The project also compares different strategies of 
sequencing by doing exome sequencing and deep sequencing of limited number 
of individuals. For our purposes however we will focus only on the whole 
genome low coverage sequencing. 
The currently available data contain 1092 individuals from 4 continents 
(379 Europeans, 286 Asians, 246 Africans and 181 Central Americans), each of 
them sequenced at a coverage of ~4x. Since we used the same sequencing 
technology and we performed similar steps of analysis, we can compare the 
variants present in the two dataset without significant adjustment to the results to 
compensate different methods of variant calling. 
 
5.3.2.Population comparison 
Since 1000G project includes different populations, we decided to compare 
their variants with the variants detected in our dataset. For the comparison, in 
Figure 13 we are plotting on the Y axis the fraction of Sardinian variants 
rediscovered by the 1000G population of interest and  on the X axis the number 
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Figure 13: Fraction of Sardinian variants rediscovered by the 3 major 1000G populations 
(Europeans, Africans, and Asians). Different lines represent different populations; different colors 
represent different frequency intervals. Height of the last point represents the variation 
discovered by the remaining individuals not included in the population of interest 
 
From geographic considerations, we expect a larger sharing between 
Sardinians and Europeans, followed by Africans and finally Asians which should 
show lower sharing for all the frequency intervals. As expected, genetic results 
match geographic expectations; however some more considerations have to be 
done. 
For common frequencies (MAF > 5%) Europeans and Africans share with 
Sardinians approximately the same amount of variation, with a slightly higher 
value for Europeans. In both cases however, about 50 individuals are enough to 
discover 95% of the common variation present in Sardinia. Part of the missing 
variation may be due to high frequency Sardinian specific variants, to variants 
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dataset. Further investigation of these variants has to be done. 
 Frequencies between 1 and 5% show an interesting difference between 
Africans and Europeans, in fact 10 Europeans individuals share a smaller number 
of variants when comparing to 10 Africans individuals since they belong to an 
older population and carry a large number of rare variants. Increasing the number 
of individuals however, the sharing between Sardinian and Europeans increases 
arriving up to 84% compared to a 68 % of the Africans individuals. The 16% 
difference may be due to rare variants recently mutated and spread in Europe and 
Sardinia but not present in Africa.  
Finally, looking at very rare variants with frequency <1%, the sharing 
between Sardinians and Europeans/Africans is extremely low, around 27%, 
because the majority of variants in this bin are very rare variants originated in 
Sardinia and not spread in the Europe/Africa. It is also interesting to see how the 
variant detected by Europeans and Africans represent almost a disjoint set, and 
even if they separately reach 27% , the total number of variants detected by the 
union of the two populations reaches 54% of the very rare variation present in 
the Sardinian population. 
To remark the consideration on paragraph 4.2.2, about imputation quality, 
the 1000G reference panel is a good dataset to investigate common variation 
present in Sardinia. However, since our goal is the investigation of the rare and 
Sardinian specific variation, the sequencing and the construction of an internal 
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5.4. A proof of concept: the LDL cholesterol in 
the Sardinia cohort 
So far we described the improvement and the benefits of the sequencing 
project to the variants discovery and to the imputation accuracy and discussed 
how these benefits may lead to higher power to detect Sardinian specific 
association’s signals. In this chapter we will show an example of a real case in 
which the Sardinia sequencing allows us to detect a variant not accessible using 
GWAS arrays or 1000G imputation.  
5.4.1. GWAS genotyping versus imputation after 
sequencing 
Here, we will focus on the association signals detected using as outcome 
the LDL cholesterol in the Sardinia cohort.  
The study of this trait involves 5949 phenotyped individuals from the 
Sardinia cohort. We tested the association using linear regression model adjusted 
using standard covariates, age ,squared age, sex. Since the individuals belong to 
families, we tested them using the Merlin[18] software, able to test association 
taking into account pedigree kinship to weight associations found in related 
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Figure 14: Manhattan plot of LDL cholesterol in the Sardinia cohort. Red points represent 
associations using GWAS arrays only, gray point the background represent association after 
imputation with the Sardinian reference panel 
 
In the Figure 14, we are showing the Manhattan plot of LDL associations, 
the scale on Y axis is the negative log10 of the association’s p-values and the 
horizontal blue line represents the significance threshold for GWAS (5x10-8). On 
the X axis there is the position in the genome, separated by chromosome. The red 
points are generated testing the association using GWAS arrays on a total on 
831,515 SNPs coming from the merging of Omni Express, Metabochip, 
Immunochip and Exomechip. The gray points in the background are generated 
testing the genotypes after the imputation on the Sardinia reference panel with 
1488 individuals, a total of 17.6 millions SNPs. 
Looking at the loci from previous GWAS studies (genes PCSK9, SORT1 on 
chromosome 1, APOB on chr2, APOE and LDLR on chr19), we can notice how 
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common variants present in the genotyping arrays. These variants have been 
found in the European populations and then they are present in the GWAS 
arrays. Their association p-value is similar to the p-value after imputation 
meaning that they are good proxies of the signal found in the gene.  
 
Figure 15: Manhattan plot of LDL cholesterol in the Sardinia cohort. The association on chr11 
shows higher association when using imputation 
 
However, focusing the attention on chromosome 11, the situation is quite 
different. Here, there is one GWAS SNP associated with a p-value 3.7x10-10, while 
the top SNP associated using sequencing is associated with a p-value 4.3x10-21 
(confirmed with direct genotyping). The SNP in the GWAS arrays, in this case, is 
a bad proxy of the top SNP found with sequencing and its association value does 
not reflect the true association of the locus. Furthermore the association detected 
with GWAS is driven by a single SNP, missing the usual pattern of association 






Detecting the Sardinian specific variability trough next generation sequencing of 2120 individuals 
Carlo Sidore - Tesi di Dottorato in Scienze Biomediche – Università degli Studi di Sassari 44 
 
5.4.2. The HBB locus 
Investigating more carefully the locus detected after imputation on 
Sardinia reference panel, we found that the top SNP rs76728603 (chr11:5248004) 
is a stop-codon mutation on the HBB gene. This mutation is extremely well 
known in Sardinia. In fact, the mutation is responsible for 95% of cases of 
thalassemia in Sardinia[19] but is also known to be protective against malaria. 
Due to very high positive selection effect against the malaria the mutation has an 
increased frequency in Sardinia (5%) compared to its extremely low frequency in 
Europe (0.03%) thus it is very hard to be detected when sequencing European 
individuals and it is very unlikely that this variant is included in GWAS arrays.  
Even if a variant associated with thalassemia and malaria may sound 
unrelated to cholesterol, the association is known since 1989[20]. The effect of the 
variant is the truncation of beta-hemoglobin chain, resulting in a reduced life 
span of red blood cells. To keep the right amount of red blood cell, individuals 
carrying the variant need an accelerated erythropoiesis which uses a larger 
amount of plasma lipids (compared to individuals without the variant) and then 
the carriers have a reduced amount of LDL cholesterol. 
 
5.4.3. Detecting the Q40X using public datasets 
We evaluated whether the variant is accessible by using different 
approaches by checking its frequency in public datasets commonly used for 
imputation.  
In the HapMap project, the variant is not present. In this case the 
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based on Affymetrix and Illumina GWAS arrays. These are two commercial 
platforms designed on general worldwide populations and designed to contain tag 
SNPs to access the largest possible variation among individuals worldwide.   
Another publicly available dataset, containing exome sequencing on 6500 
individuals (2200 African Americans and 4300 European Americans) has only a 
copy of the alternative allele on a total of 13,000 chromosomes. Unfortunately 
this is an exome sequencing based study and it is not possible to use the data for 
imputation. 
Finally we analyzed the variant in the 1092 individuals sequenced by the 
1000G project. Again, the variant is just a singleton in 2184 chromosomes and 
unexpectedly the only carrier of the heterozygote genotype is a Mexican 
individual, confirming once again its low frequency in Europe. Since 1000G data 
generated a reference panel for imputation we decided to run the imputation to 
understand whether the association signal is detectable by using the 1000G 
external reference panel.  
 We evaluated the association signals around the HBB variant, after 
imputation on the same GWAS array with two different reference panels, the 
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Figure 16: LocusZoom on the HBB mutation region. Left panel plots the results after 1000G 
imputation, right panel plots the results after Sardinian reference panel imputation. Dot colors 
represent the degree of linkage disequilibrium (r2) with the HBB variant 
  
 Using the 1000G panel, the HBB Q40X variant shows an association p-
value of 0.9, thus the association signal is completely missed due to the very low 
imputation accuracy (rsqr = 0.31). Since the 1000G reference panel does not 
contain the Sardinian haplotypes with the Q40X mutation and the Q40X 
mutation is a singleton, the imputation quality is extremely low, generating 
wrong genotypes and producing a p-value completely different from the real 
value. 
 When using the Sardinian reference panel, the imputation quality is much 
higher (rsqr=0.92) and the p-value on imputed genotypes matches the p-value 
obtained after direct genotyping of the variant, confirming once again the 
benefits of using the reference panel generated by sequencing individuals from 
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6.1. Analyses performed 
With the goal of investigating the Sardinian specific variability we 
sequenced 2120 individuals using whole genome low pass sequencing approach. 
We performed alignment and quality checks of the sequence samples and we 
called the variant sites using a population based approach. We filtered variants 
using stringent criteria and applied genotype refinement algorithms to increase 
the genotype accuracy and to produce phased haplotypes. After removing the 
related individuals we generated a reference panel for imputation and we 
genotyped in silico a total of 15,000 individuals involved in a study of quantitative 
traits in the Ogliastra region and in a study of autoimmune diseases in Sardinia. 
We evaluated the benefits of using a Sardinian reference panel to genotype in 
silico Sardinian individuals and we showed the improvement in term of 
genotyping accuracy and power to detect association signals especially for rare 
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We detected a total of 17.6 millions variants, 30.6% of these variants are 
novel when comparing to the latest release of dbSNP and more than 5 millions 
variants (50% of the rare variants) are novel in the allelic frequencies below 1%.  
We compared the variant sites detected in our project with the variant 
found by the 1000G consortium in the European, African and Asian population, 
evaluating the allele sharing between these populations and the Sardinian 
population. 
Finally, we provided a real example on the detection of a stop-codon 
variant in the HBB gene and we showed how the detection of this signal is 
problematic when using large scale approaches based on GWAS arrays and 
imputation using reference panels not containing Sardinian individuals. 
6.2. Future work 
Our future plans include the analyses and application of the existing 
pipeline to an extension of the existing dataset to arrive to a total sample size of 
3400 individuals sequenced. 
We will also perform the variant calling of complex variants, like CNV, 
indels and structural variation to better understand the Sardinian variability and 
to have a more complete overview of the genetic underlying the phenotypic 
variability in the quantitative traits of the SardiNIA project and in the 
autoimmune diseases studied in our case-control study. 
We will also use the sequencing data to start some analysis on the 
population genetics of Sardinia, trying to evaluate coalescence times for our 
sequences, differences in allele frequencies with Europeans and selection signals 
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